Thomas E. Tarara

1.6k total citations
31 papers, 1.3k citations indexed

About

Thomas E. Tarara is a scholar working on Pulmonary and Respiratory Medicine, Food Science and Pharmaceutical Science. According to data from OpenAlex, Thomas E. Tarara has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Food Science and 6 papers in Pharmaceutical Science. Recurrent topics in Thomas E. Tarara's work include Inhalation and Respiratory Drug Delivery (18 papers), Microencapsulation and Drying Processes (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Thomas E. Tarara is often cited by papers focused on Inhalation and Respiratory Drug Delivery (18 papers), Microencapsulation and Drying Processes (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Thomas E. Tarara collaborates with scholars based in United States, Paraguay and United Kingdom. Thomas E. Tarara's co-authors include Jeffry G. Weers, Andrew R. Clark, Peter H. Hirst, Danforth P. Miller, Daniel J. Smıth, Sarma P. Duddu, Yulia H. Walter, Andrew Clark, Luis Dellamary and Alexey Kabalnov and has published in prestigious journals such as Langmuir, Journal of Colloid and Interface Science and CHEST Journal.

In The Last Decade

Thomas E. Tarara

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Thomas E. Tarara

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Tarara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Tarara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Tarara more than expected).

Fields of papers citing papers by Thomas E. Tarara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Tarara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Tarara. The network helps show where Thomas E. Tarara may publish in the future.

Co-authorship network of co-authors of Thomas E. Tarara

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Tarara. A scholar is included among the top collaborators of Thomas E. Tarara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Tarara. Thomas E. Tarara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Formulation of Dry Powders for Inhalation Comprising High Doses of a Poorly Soluble Hydrophobic Drug 2022 ·Thomas E. Tarara, Danforth P. Miller, (unknown), Ariel R. Muliadi, Jerry Tso, (unknown), Jeffry G. Weers	22
2	Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects 2020 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Michael A. Eldon, (unknown), (unknown), Thomas E. Tarara, Jerry Okikawa, Jeffry G. Weers	6
3	Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles 2019 ·AAPS PharmSciTech ·Jeffry G. Weers, Danforth P. Miller, Thomas E. Tarara	45
4	Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination 2018 ·Pulmonary Pharmacology & Therapeutics ·Pamela J. McShane, Jeffry G. Weers, Thomas E. Tarara, (unknown), (unknown), Danforth P. Miller, (unknown), Elisabeth Operschall, J.S. Elborn	49
5	Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract? 2018 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Jeffry G. Weers, Yoen‐Ju Son, (unknown), (unknown), (unknown), (unknown), (unknown), Xue Li, Richard Malcolmson, Danforth P. Miller, Thomas E. Tarara, (unknown), Andrew R. Clark	28
6	Cleaning verification: Exploring the effect of the cleanliness of stainless steel surface on sample recovery 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·Imad A. Haidar Ahmad, James P. Tam, Xue Li, (unknown), Thomas E. Tarara, Andrei Blaskó	6
7	Design of fine particles for pulmonary drug delivery 2007 ·Expert Opinion on Drug Delivery ·Jeffry G. Weers, Thomas E. Tarara, Andrew Clark	98
8	Characterization of Suspension-Based Metered Dose Inhaler Formulations Composed of Spray-Dried Budesonide Microcrystals Dispersed in HFA-134a 2004 ·Pharmaceutical Research ·Thomas E. Tarara, (unknown), (unknown), (unknown), Jeffry G. Weers	46
9	Characterization of Fluorocarbon-in-Water Emulsions With Added Triglyceride 2004 ·Langmuir ·Jeffry G. Weers, (unknown), Thomas E. Tarara, T. J. Pelura	12
10	Inhalation of a Dry Powder Tobramycin PulmoSphere Formulation in Healthy Volunteers 2003 ·CHEST Journal ·Michael T. Newhouse, Peter H. Hirst, Sarma P. Duddu, Yulia H. Walter, Thomas E. Tarara, Andrew R. Clark, Jeffry G. Weers	160
11	In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler 2002 ·Pharmaceutical Research ·Peter H. Hirst, Gary R. Pitcairn, (unknown), Thomas E. Tarara, Andrew R. Clark, Luis Dellamary, Graham L. Hall, Jolene Shorr, Stephen P. Newman	68
12	Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia 2002 ·Critical Care Medicine ·Eric W. Dickson, Stephen O. Heard, Thomas E. Tarara, Jeffry G. Weers, Angela B. Brueggemann, Gary V. Doern	25
13	Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder 2002 ·Pharmaceutical Research ·Sarma P. Duddu, (unknown), Yulia H. Walter, Thomas E. Tarara, (unknown), Andrew R. Clark, Michael A. Eldon, (unknown), (unknown), Peter H. Hirst, Stephen P. Newman, Jeffry G. Weers	117
14	Liquid Dose Pulmonary Instillation of Gentamicin PulmoSpheres® Formulations: Tissue Distribution and Pharmacokinetics in Rabbits 2001 ·Pharmaceutical Research ·Daniel J. Smıth, (unknown), Thomas E. Tarara, Diana Meays, Luis Dellamary, Catherine M. Woods, Jeffry G. Weers	25
15	Receptor-Mediated Targeting of Spray-Dried Lipid Particles Coformulated with Immunoglobulin and Loaded with a Prototype Vaccine 2001 ·Pharmaceutical Research ·Adrian Bot, Daniel J. Smıth, Simona Bot, Luis Dellamary, Thomas E. Tarara, (unknown), William T. Phillips, Jeffry G. Weers, Catherine M. Woods	24
16	Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract 2000 ·Pharmaceutical Research ·Adrian Bot, Thomas E. Tarara, Daniel J. Smıth, Simona Bot, Catherine M. Woods, Jeffry G. Weers	73
17	EFFICACY OF A NOVEL PERFLUOROCARBON-BASED INTRAPULMONARY DRUG DELIVERY SYSTEM 1998 ·Critical Care Medicine ·Eric W. Dickson, Stephen O. Heard, (unknown), Thomas E. Tarara, Angela B. Brueggemann, Gary V. Doern	3
18	Oxidative Assessment of Phospholipid-Stabilized Perfluorocarbon-Based Blood Substitutes 1994 ·Artificial Cells Blood Substitutes and Biotechnology ·Thomas E. Tarara, (unknown), T. J. Pelura	5
19	Stabilization of Perflubron Emulsions with Egg Yolk Phospholipid 1992 ·Biomaterials Artificial Cells and Immobilization Biotechnology ·T. J. Pelura, (unknown), Thomas E. Tarara, Jeffry G. Weers	5
20	[45] Incorporation of β-carotene into mixed micelles 1990 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Louise M. Canfield, Thomas Fritz, Thomas E. Tarara	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact